Home | Infections | Hepatitis


New Hepatitis C Treatment Needs No Antiviral Boost

The drug approved to treat patients infected with the hepatitis C virus needs no help from other antivirals, according to a study ...

Helping doctors predict what’s next for patients diagnosed with Hepatitis C

Patient risk model can help target costly HCV treatment to those with most urgent need ...

Hepatitis C success based on strong research

The new hepatitis C drugs represent a genuine breakthrough in pharmaceutical research, and would not have been possible without the work done on the virus by Charles Rice at Rockefeller University. Dr Rice is now coming to Sweden to speak about hepatitis C for the annual Nicholson lecture, where an introduction will be given by one of Sweden’s best-known hepatitis C patients, Professor Hans Rosling. ... Full story

Lives could be saved with hepatitis C treatment

In a letter to the Medical Journal of Australia published today, a Monash University-led team is asking for hepatitis C virus patients to gain improved access to drugs to prevent liver related deaths. ... Full story

WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers

GENEVA - WHO today published the new edition of its Model List of Essential Medicines which includes ground-breaking new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia) and multi-drug resistant tuberculosis (TB), among others. The move opens the way to improve access to innovative medicines that show clear clinical benefits and could have enormous public health impact globally. ... Full story

Interferon-Free Therapy Clears Hepatitis C in 93 Percent of Patients in Trial

By Duke Medicine News and Communications - DURHAM, N.C. – A 12-week dose of an investigational three-drug hepatitis C combination cleared the virus in 93 percent of patients with liver cirrhosis who hadn’t previously been treated, according to a study in the May 5, 2015, issue of The Journal of the American Medical Association. ... Full story

CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High

Despite More Than 25 Years of Universal Hepatitis B Vaccination ... Full story

Unimmunized Infants at Higher Risk of Hepatitis B

Timely immunoprophylaxis shortly after birth and completion of the hepatitis B vaccine series prevents most transmission of perinatal hepatitis B virus. ... Full story

Study revelas alcoholic hepatitis treatments fail to keep patients alive

Leading experts are calling for urgent research into the prevention and treatment of alcoholic hepatitis as a major study reveals the only drugs used to treat the illness are not effective as currently used. ... Full story

Boosting the malaria battle-line

Electron microscope image generated by Dr Mauro Maiorca, University of Melbourne, Australia. ... Full story

1 2 3 4 5 6 7 8 9 next total: 81 | displaying: 1 - 10